Founded by practicing physicians, we at EpicentRx cherish what disease tries to perish—human health and wellbeing. We are on a mission—hence the mission statement—to raise the clinical bar with non-toxic therapies that will potentially improve not only quantity but also, perhaps even more importantly, at least to patients and their families, quality of life. If a modest improvement in survival comes at the cost of increased toxicity that degrades quality of life and general enjoyment of life we say, “so what?” and “how exactly is this a benefit?”  This patient-centric, point of view is what drives us to develop therapies like RRx-001 and the oncolytic virus VIMMUNE™ platform that targets the disease rather than the person. In the not-too-distant future we fervently hope to add a permanent “re” to this webpage title, making it a remission statement.